Biogen Receives EC Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
On Sept. 17, 2025, Biogen announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE® (zuranolone)…